Dutasteride vs Finasteride: An Honest Comparison of Potency, Risk and Washout
How dutasteride and finasteride differ in enzyme targets, DHT suppression, half-life and approval status — and why the washout window matters more than potency.

You're fourteen months in. The photos say finasteride did something — the temples stopped retreating, the crown looks about the same as it did last spring — but "about the same" was not what you were picturing when you started.
So you go back to the thread you've been reading for a year. And somewhere around the fortieth reply, a stranger with a five-figure post count writes: just switch to dut, it's the same thing but it works.
Same thing but it works. You save the tab. You start googling.
It is not the same thing, and the difference that actually matters isn't the one that stranger was talking about.
Dutasteride blocks more of the enzyme family than finasteride and suppresses DHT far more completely — but it also stays in your body for months rather than a day. That washout gap, not the potency gap, is the real decision. Both are prescription drugs that require a doctor's evaluation.
Key numbers
- Finasteride inhibits type II 5-alpha-reductase (and type III to a lesser degree). Dutasteride inhibits types I, II and III — a dual inhibitor.
- Serum DHT falls by roughly 70% on finasteride 1 mg, versus over 90% on dutasteride 0.5 mg.
- Terminal half-life: about 5–6 hours for finasteride, about 5 weeks for dutasteride — which remains detectable in serum for months after the last dose.
- Approval status differs by country. Dutasteride is licensed for male pattern hair loss in South Korea and Japan; in the US, UK and EU it is licensed for enlarged prostate only.
- Blood donation deferral reflects that gap: typically one month after finasteride, six months after dutasteride.
What's the actual mechanical difference?
Both drugs do the same job on the same pathway — they just cover different amounts of it. 5-alpha-reductase converts testosterone into DHT, the androgen that miniaturises follicles in men genetically susceptible to pattern hair loss. The enzyme exists in more than one form, distributed differently around the body.
Finasteride targets type II, which is concentrated in hair follicles, the prostate and genital skin. That's a well-aimed shot at the tissue causing the problem. Dutasteride adds type I, which is more widely distributed — including in skin and liver — and covers type III as well.
That's the whole story of the potency gap. Dutasteride isn't a different class of drug or a smarter molecule. It is the same intervention with a wider blast radius, which is exactly why it suppresses DHT more completely and why the trade-offs scale with it. Broader coverage buys you a better shot at the follicle and, unavoidably, more hormonal change everywhere else.
The honest caveat: "more DHT suppression" is a lab measurement, not a hair outcome. The relationship between serum DHT and scalp DHT isn't one-to-one, and individual response varies enormously.
How do they compare side by side?
| Finasteride | Dutasteride | |
|---|---|---|
| Enzyme targets | Type II (some III) | Types I, II and III |
| Serum DHT reduction | ~70% | >90% |
| Typical hair-loss dose | 1 mg daily | 0.5 mg daily (off-label in most markets) |
| Terminal half-life | ~5–6 hours | ~5 weeks |
| Hair-loss approval | US, UK, EU and widely | South Korea, Japan |
| If you react badly | Clears in about a day | Months to wash out |
| Effect on PSA | Roughly halves it | Roughly halves it |
The row that should change your thinking is the second-to-last one. Everything else is a difference of degree; that one is a difference in kind.
Is dutasteride "off-label" a problem?
Off-label prescribing is legal, common, and often good medicine — but it changes who is carrying the risk assessment. When a drug is approved for an indication, a regulator has reviewed trial data at that dose, in that population, for that purpose, and signed off. Off-label means no regulator has done that for your use case; your doctor is extrapolating from prostate data plus a smaller hair-loss literature.
For dutasteride and hair loss, that extrapolation is better-supported than most off-label use. It's licensed for exactly this purpose in two countries, and head-to-head trials against finasteride exist. That's a long way from unfounded.
But it means three things practically. Dosing conventions are inherited rather than established. Long-term hair-loss-specific safety data is thinner than finasteride's, which has decades and enormous exposure behind it. And in some markets you'll find it easier to obtain from a telehealth service than from a physician who knows your history — which is precisely the wrong direction to solve this problem in.
Is the side effect profile different?
The categories are the same; what changes is exposure and recovery time. Both drugs list sexual effects (reduced libido, erectile difficulty, ejaculation changes), breast tenderness or enlargement, mood changes including depression, and rash. Both are contraindicated around pregnancy — women who are or may become pregnant should not handle either. Both roughly halve PSA, which any doctor screening your prostate must be told about.
Trials generally show broadly comparable rates between the two, though with more complete DHT suppression it's reasonable to expect the dutasteride column to sit somewhat higher in real-world use. The bigger issue is what I'd call the washout question, and it's the one I'd want answered before I swallowed anything:
If this goes badly, how long am I stuck with it?
On finasteride, the answer is about a day of drug clearance, with symptoms typically resolving over the following weeks. On dutasteride, you are committed to a decision that takes months to unwind. That doesn't make dutasteride unsafe — it makes it a heavier bet. And a heavier bet is a fine thing to place once you already know how you tolerate the lighter one.
For the full picture on what you'd be tolerating either way, finasteride side effects goes through the categories, the contested reversibility debate, and how to build a stop rule.
Who should actually consider switching?
Not the man fourteen months in who's disappointed. The sensible candidates are narrower than the forums suggest:
- You've completed a genuine finasteride trial — twelve months minimum, taken consistently, with standardised photos rather than mirror impressions.
- You tolerated it cleanly. Tolerating finasteride is the closest thing to a real-world screening test for whether heavier suppression will suit you.
- The photos show clear ongoing loss, not just "not as thick as I wanted."
- You've optimised the cheaper variables first — topical minoxidil used properly, scalp health handled, sleep and stress not wrecked.
- You accept the washout, out loud, in front of a doctor who has your history.
If more than one of those is missing, the higher-yield move is usually fixing adherence or adding a topical rather than escalating the molecule.
One thing worth saying plainly: hair loss is not an emergency, and treating it like one produces bad decisions made at midnight. Men who escalate slowly, document properly and involve a doctor consistently do better than men who chase potency. And if you decide to stop treating altogether and just cut it short, that is a genuinely good outcome too — a well-kept head reads far better than a defended one.
The bottom line
Dutasteride blocks three 5-alpha-reductase subtypes and cuts DHT by over 90%; finasteride blocks one main subtype and cuts it by around 70%. Dutasteride is likely somewhat more effective for hair, is licensed for it in only a couple of countries, and — critically — takes months rather than a day to leave your system. Earn the switch with a completed, well-tolerated finasteride trial and a real prescriber. Neither drug belongs in a shopping cart you filled yourself.
Before you escalate anything, it's worth knowing what your hair is actually costing you in the only place it matters: someone else's first glance. Our free test reads your face and presentation the way a stranger does, and it's free once you upload. It won't prescribe anything. It'll tell you where hair sits among everything else people register — which is usually further down than men expect. How to stop a receding hairline covers the full menu, and how to look more attractive men covers the rest of the picture.
Frequently asked questions
Is dutasteride stronger than finasteride?
Yes, measurably. Finasteride blocks type II 5-alpha-reductase and lowers circulating DHT by roughly 70%. Dutasteride blocks types I, II and III and lowers it by over 90%. Head-to-head studies generally favour dutasteride on hair counts — the trade is broader hormonal suppression and a far longer washout.
Is dutasteride approved for hair loss?
It depends where you are. Dutasteride is approved for male pattern hair loss in South Korea and Japan. In the US, UK and EU it is approved for enlarged prostate only, so hair loss use is off-label. Off-label prescribing is legal and routine, but it means you're relying on your doctor's judgement rather than a regulator's.
How long does dutasteride stay in your system?
Far longer than finasteride. Dutasteride's terminal half-life is around five weeks, and it remains detectable in serum for months after the last dose. Finasteride's is roughly five to six hours. If you react badly, finasteride clears in about a day; dutasteride does not.
Can I switch from finasteride to dutasteride?
Only with a doctor. Both are prescription medications, both lower PSA readings, both are contraindicated around pregnancy, and switching changes your risk profile in ways worth discussing rather than guessing at. If you're still deciding whether treatment is worth it, our free test shows how your hairline actually reads to a stranger.
